Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Semaglutide in Nonalcoholic Fatty Liver Disease [Phase 4]
Phase 4 clinical trial update for semaglutide in nonalcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Effects of High-Intensity Interval Training Exercise in Adolescents With Hepatosteatosis [NA]
A completed clinical trial evaluated the effects of high-intensity interval training on adolescents with hepatosteatosis (Non-Alcoholic Fatt…
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome [Phase 4]
Phase 4 trial updating the efficacy of canagliflozin versus metformin in women with polycystic ovary syndrome and non-alcoholic fatty liver …
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial update for Curcuvail in fatty liver disease completed.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD) [Phase 3]
Phase 3 trial evaluating Secukinumab for plaque psoriasis with coexisting NAFLD was terminated; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities [Phase 4]
Phase 4 trial evaluating safety and effectiveness of saroglitazar 4 mg in patients with NAFLD and comorbidities.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease [Phase 4]
Phase 4 trial update for henagliflozin in patients with type 2 diabetes and nonalcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue [Phase 1, Phase 2]
Clinical trial update investigating a GLP-1/GIP analogue for non-alcoholic fatty liver disease in patients with type 2 diabetes; phase 1/2 w…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver [Phase 4]
A Phase IV trial of Huazhi Rougan Granule for non-alcoholic simple fatty liver has completed, assessing efficacy and safety in real-world us…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: A Phase IV Study of Huazhi Rougan Granule [Phase 4]
Phase IV trial investigating efficacy and safety of Huazhi Rougan Granule for non-alcoholic fatty liver disease has been completed.
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Effect of Empagliflozin on Liver Fat in Non-diabetic Patients [Phase 4]
Phase 4 trial updating the effects of empagliflozin on liver fat in non-diabetic patients with non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy [Phase 3]
Phase 3 clinical trial assessing Godex Carnitine Orotate Complex for efficacy in nonalcoholic fatty liver disease is currently enrolling by …
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial update evaluating a high oral loading dose of cholecalciferol (vitamin D3) in non-alcoholic fatty liver disease has b…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Probiotic Supplementation IN NAFLD Patients [Phase 4]
Phase 4 clinical trial updating probiotic supplementation in patients with non-alcoholic fatty liver disease (NAFLD) has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM [Phase 2]
Phase 2 clinical trial updating real-world use of semaglutide for liver fibrosis associated with non-alcoholic fatty liver disease in obese …
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients [Phase 3]
Phase 3 study update assessing safety and biomarkers of resmetirom (MGL-3196) for non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease [NA]
A clinical trial investigating quantitative ultrasound with Liver InCytes for evaluating non-alcoholic fatty liver disease was terminated; r…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients [Phase 4]
Phase 4 trial comparing febuxostat to allopurinol in patients with MAFLD-related hepatic steatosis and hyperuricemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD [Phase 4]
Phase 4 trial evaluating the efficacy of empagliflozin and pioglitazone in patients with type 2 diabetes and non-alcoholic fatty liver disea…
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function [Phase 2]
Phase 2 clinical trial update evaluating the effect of Coenzyme Q10 on endothelial, vascular, and myocardial function in non-alcoholic fatty…
-
CLINICAL_TRIALS research · 2023-06-15Clinical Trial Update: Interventional Strategy in Tackling Emerging Non-alcoholic Fatty Liver Disease in Childhood Obesity [Phase 4]
Phase 4 interventional trial update addressing emerging non-alcoholic fatty liver disease in childhood obesity.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis [Phase 2]
A Phase 2 clinical trial evaluating CC-90001 for non-alcoholic fatty liver disease and liver cirrhosis was terminated; results were posted i…
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial investigating the effects of empagliflozin on liver fat content, energy metabolism, and body composition in patients with type…
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) [Phase 2]
A Phase 2 randomized, double-blind study evaluating vitamin E and DHA-EE for non-alcoholic fatty liver disease, completed with results poste…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects [Phase 2]
Phase 2 open-label trial evaluating MN-001 on HDL and triglycerides in subjects with NASH/NAFLD completed with results posted.